WHO ICTRP trial
Clinical trial on Immunity and antiviral for quarantine patients of COVID-19
CTRI/2020/06/025527 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/06/025527 |
|---|---|
| Public title | Clinical trial on Immunity and antiviral for quarantine patients of COVID-19 |
| Scientific title | â??A Prospective, Open label, Randomized-controlled study to evaluate the efficacy and safety of Amrta Karuna Syrup in mildly symptomatic COVID- 19 patientsâ?? |
| Primary sponsor | Vopec Pharmaceuticals Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: Amrta Karuna Syrup: Dosage Form: syrup Dose: 15 ml Frequency: 2 times daily after meal Route of administration: oral Duration of therapy: 14 days Control Intervention1: Standard treatment as per hospital protocol for COVID… |
| Registration date | Jan 6, 2020 |
| Target size | 42 |
| Secondary IDs | CT/Vopec/Amrta Karuna /2020 version 1.0 dated 24th Apr 2020 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: